Kfar Saba, Israel

Annat Raiter

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 3.5

ph-index = 2

Forward Citations = 55(Granted Patents)


Company Filing History:


Years Active: 2006-2014

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Annat Raiter

Introduction

Annat Raiter is a notable inventor based in Kfar Saba, Israel. He has made significant contributions to the field of biotechnology, particularly in the area of angiogenesis. With a total of 6 patents to his name, Raiter has developed innovative methods and compositions that have the potential to impact medical treatments.

Latest Patents

Among his latest patents is a groundbreaking invention titled "Compositions and methods for inducing angiogenesis." This patent details an isolated peptide comprising an amino acid sequence HWRR, as set forth by SEQ ID NO:5. The peptide consists of 4 or 5 amino acids and is designed to treat angiogenesis-related pathologies. Raiter's work in this area highlights the importance of peptides in therapeutic applications.

Career Highlights

Throughout his career, Annat Raiter has worked with several prominent companies, including Curetech Ltd. and Mor Research Applications Ltd. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in medical research.

Collaborations

Raiter has collaborated with various professionals in his field, including Britta Hardy and Leah Klapper. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Annat Raiter's contributions to the field of biotechnology, particularly in angiogenesis, demonstrate his commitment to advancing medical science. His innovative patents and collaborations with industry professionals underscore his role as a leading inventor in his field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…